DUBLIN, Sept. 16, 2020 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced new data from the landmark WRAP-IT study, showing the TYRX™ Absorbable ...

) has received CE (Conformité Européenne) Mark for the TYRX(TM) Absorbable Antibacterial Envelope. This innovative mesh envelope covers an implantable cardiac device to help stabilize the device after ...

One innovative device increasingly championed by cardiologists as a demonstrated deterrent against CIED infection is the TYRX™ Absorbable Antibacterial Envelope. The surgical mesh Envelope holds CIEDs ...

Worldwide, an estimated 1.5 million patients receive a cardiovascular implantable electronic device (CIED) such as a pacemaker or implanted defibrillator each year. However, in approximately 1% to 4% ...

(RTTNews) - Medical technology firm Medtronic plc (MDT) announced Monday that new data from the landmark WRAP-IT study published in Heart Rhythm, demonstrated a significantly lower infection risk for ...

Earlier this month, Medtronic announced FDA clearance of the TYRX Neuro Absorbable Antibacterial Envelope to be used with implantable neurostimulators (INS). The product, a mesh envelope into which ...

DUBLIN, Sept. 22, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, has received Breakthrough Device Designation status from the U.S. Food and Drug Administration ...

> Medtronic ($MDT) has started what it expects to be a 7,000-patient trial for the Tyrx Absorbable Antibacterial Envelope to reduce major infections in surgical ...

DENVER--(BUSINESS WIRE)--Use of TYRX, Inc.’s AIGISRx ® Antibacterial Envelope significantly reduced device infection rates in patients at high risk for device infection who received cardiovascular ...

Scientists at Tomsk Polytechnic University have learned how to regulate the swelling and erosion properties of antibacterial gels based on deep eutectic solvents (DES) by changing the polymer in their ...